Nicolas Dubuisson

579 total citations
23 papers, 364 citations indexed

About

Nicolas Dubuisson is a scholar working on Molecular Biology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Nicolas Dubuisson has authored 23 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Neurology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Nicolas Dubuisson's work include Muscle Physiology and Disorders (7 papers), Peripheral Neuropathies and Disorders (6 papers) and Multiple Sclerosis Research Studies (6 papers). Nicolas Dubuisson is often cited by papers focused on Muscle Physiology and Disorders (7 papers), Peripheral Neuropathies and Disorders (6 papers) and Multiple Sclerosis Research Studies (6 papers). Nicolas Dubuisson collaborates with scholars based in Belgium, United Kingdom and Spain. Nicolas Dubuisson's co-authors include Michel Abou‐Samra, Gavin Giovannoni, Sonia Brichard, Klaus Schmierer, David Baker, Zhifeng Mao, Hilary Longhurst, Francesca Ammoscato, Benjamin M. Jacobs and Sharmilee Gnanapavan and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Journal of the Neurological Sciences.

In The Last Decade

Nicolas Dubuisson

22 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Dubuisson Belgium 11 147 100 68 66 64 23 364
Xiao Zhu United States 9 81 0.6× 79 0.8× 73 1.1× 24 0.4× 24 0.4× 25 301
Giuseppe Meucci Italy 15 141 1.0× 68 0.7× 78 1.1× 90 1.4× 58 0.9× 25 647
Qiangping Wang China 11 60 0.4× 189 1.9× 48 0.7× 46 0.7× 71 1.1× 22 503
Bernice Kuca United States 8 139 0.9× 46 0.5× 66 1.0× 65 1.0× 23 0.4× 10 523
M. Mäurer Germany 11 215 1.5× 40 0.4× 92 1.4× 46 0.7× 53 0.8× 27 433
Michael Dinizo United States 10 205 1.4× 105 1.1× 32 0.5× 17 0.3× 122 1.9× 18 484
A Schlüter Germany 11 98 0.7× 58 0.6× 30 0.4× 30 0.5× 19 0.3× 28 333
Carolina Moreno Portugal 13 141 1.0× 35 0.3× 47 0.7× 84 1.3× 115 1.8× 48 490
Halina Borgiel−Marek Poland 10 39 0.3× 159 1.6× 59 0.9× 44 0.7× 84 1.3× 29 419
RK Gherardi France 7 73 0.5× 49 0.5× 53 0.8× 49 0.7× 62 1.0× 9 404

Countries citing papers authored by Nicolas Dubuisson

Since Specialization
Citations

This map shows the geographic impact of Nicolas Dubuisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Dubuisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Dubuisson more than expected).

Fields of papers citing papers by Nicolas Dubuisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Dubuisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Dubuisson. The network helps show where Nicolas Dubuisson may publish in the future.

Co-authorship network of co-authors of Nicolas Dubuisson

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Dubuisson. A scholar is included among the top collaborators of Nicolas Dubuisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Dubuisson. Nicolas Dubuisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ricci, Giulia, Lucia Ruggiero, Liliana Vercelli, et al.. (2025). Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation form. Neurological Sciences. 46(9). 4633–4643. 1 indexed citations
2.
Peeters, Ronald, Nicolas Dubuisson, Peter Van den Bergh, et al.. (2024). Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient‐reported outcome measures. European Journal of Neurology. 31(7). e16282–e16282. 5 indexed citations
3.
Abou‐Samra, Michel, Nicolas Dubuisson, Alice Marino, et al.. (2024). Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy. Antioxidants. 13(12). 1551–1551.
4.
Carrizosa, María A. Davis‐López de, et al.. (2024). Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield. Antioxidants. 13(9). 1073–1073. 2 indexed citations
5.
Dubuisson, Nicolas, Mónica Marta, Sharmilee Gnanapavan, et al.. (2023). Anaesthetic management of people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 80. 105045–105045. 2 indexed citations
6.
Dubuisson, Nicolas, María A. Davis‐López de Carrizosa, Laurence Noël, et al.. (2023). The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle. Cells. 12(16). 2101–2101. 7 indexed citations
7.
Dubuisson, Nicolas, et al.. (2022). Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy. Frontiers in Immunology. 13. 1049076–1049076. 11 indexed citations
8.
Dubuisson, Nicolas, et al.. (2021). Walking down Skeletal Muscle Lane: From Inflammasome to Disease. Cells. 10(11). 3023–3023. 17 indexed citations
9.
Dubuisson, Nicolas, et al.. (2021). SARS-CoV-2-associated Guillain–Barré syndrome in four patients: what do we know about pathophysiology?. Acta Neurologica Belgica. 122(3). 703–707. 4 indexed citations
10.
Dubuisson, Nicolas, et al.. (2021). DMD – ANIMAL MODELS. Neuromuscular Disorders. 31. S76–S76. 2 indexed citations
11.
Abou‐Samra, Michel, et al.. (2020). Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?. International Journal of Molecular Sciences. 21(7). 2620–2620. 54 indexed citations
12.
Axelsson, Markus, Nicolas Dubuisson, Lenka Novakova, et al.. (2019). Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies. Acta Neurologica Scandinavica. 139(5). 422–427. 6 indexed citations
13.
Jacobs, Benjamin M., David Baker, Nicolas Dubuisson, et al.. (2018). Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells. Journal of Neurology. 265(5). 1199–1209. 113 indexed citations
14.
Yıldız, Özlem Kayım, Nicolas Dubuisson, Gavin Giovannoni, et al.. (2018). Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine. Multiple Sclerosis and Related Disorders. 24. 20–27. 14 indexed citations
15.
Dubuisson, Nicolas, Mark G. Buckley, Mónica Marta, et al.. (2017). Validation of an environmentally-friendly and affordable cardboard 9-hole peg test. Multiple Sclerosis and Related Disorders. 17. 172–176. 10 indexed citations
16.
Dubuisson, Nicolas, et al.. (2017). Self-monitoring visual function via a smartphone application. Journal of the Neurological Sciences. 381. 479–479. 1 indexed citations
17.
Dubuisson, Nicolas, Fabìola Puentes, Gavin Giovannoni, & Sharmilee Gnanapavan. (2017). Science is 1% inspiration and 99% biomarkers. Multiple Sclerosis Journal. 23(11). 1442–1452. 20 indexed citations
18.
Dubuisson, Nicolas, David Baker, Angray S. Kang, et al.. (2017). Alemtuzumab depletion failure can occur in multiple sclerosis. Immunology. 154(2). 253–260. 21 indexed citations
19.
Dubuisson, Nicolas, Vincent Van Pesch, & Peter Van den Bergh. (2016). Cramp‐fasciculation syndrome associated with monofocal motor neuropathy. Muscle & Nerve. 56(4). 828–832. 1 indexed citations
20.
Dupuis, M., et al.. (2011). Takotsubo syndrome (TKS): A possible mechanism of sudden unexplained death in epilepsy (SUDEP). Seizure. 21(1). 51–54. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao Zhu Breakdown of academic impact, for papers by Giuseppe Meucci Breakdown of academic impact, for papers by Qiangping Wang Breakdown of academic impact, for papers by Bernice Kuca Breakdown of academic impact, for papers by M. Mäurer Breakdown of academic impact, for papers by Michael Dinizo Breakdown of academic impact, for papers by A Schlüter Breakdown of academic impact, for papers by Carolina Moreno Breakdown of academic impact, for papers by Halina Borgiel−Marek Breakdown of academic impact, for papers by RK Gherardi
Rankless by CCL
2026